Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus).

Experimental autoimmune encephalomyelitis in the common marmoset, a nonhuman primate species (Callithrix jacchus), is a new model for multiple sclerosis. Given the close immunological relationship between marmosets and humans, it is an attractive model for investigating immunopathological pathways relevant to multiple sclerosis and to evaluate new treatments for the disease. Unlike in the originally documented model, experimental autoimmune encephalomyelitis induced without the use of Bordetella pertussis led to a chronic disease of moderate severity. The clinical course of experimental autoimmune encephalomyelitis in the present model was mainly chronic and progressive, but periods of incomplete remission did occur. At the chronic stage of the disease, actively demyelinating lesions were found together with inactive demyelinated and remyelinated (shadow) plaques. Before immunization and during clinically active experimental autoimmune encephalomyelitis, T1- and T2-weighted magnetic resonance brain images were obtained. Correlation of the data from the magnetic resonance images and the neuropathology analysis revealed that the hyperintense regions in T2-weighted images represented both active and inactive remyelinating lesions. Quantification showed that the number of lesions in T2-weighted magnetic resonance images equalled those found by pathological examination, and thus T2-weighted magnetic resonance imaging can be used to discern the total lesion load. Extravasation of gadolinium-diethylenetriamine-penta-acetic acid (triple dose) was found only in lesions, which by histopathology were shown to be engaged in the process of active demyelination.

[1]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[2]  Noseworthy Jh.  Clinical trials in multiple sclerosis. , 1993, Current opinion in neurology and neurosurgery.

[3]  R. Bontrop,et al.  Evolution of Major Histocompatibility Complex Polymorphisms and T‐Cell Receptor Diversity in Primates , 1995, Immunological reviews.

[4]  B. Schoenberg,et al.  Controlled Clinical Trials in Neurological Disease , 2011, Foundations of Neurology.

[5]  H. Lassmann,et al.  Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination , 1998, Annals of neurology.

[6]  A. S. Hall,et al.  NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.

[7]  F. Barkhof,et al.  Pre- and post-mortem MR imaging of unsuspected multiple sclerosis in a patient with Alzheimer's disease , 1993, Journal of the Neurological Sciences.

[8]  H. Lassmann,et al.  Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus) , 1998, Journal of Neuroimmunology.

[9]  M. Foerster,et al.  Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset. , 1995, Life sciences.

[10]  H P Hartung,et al.  In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. , 1996, Brain : a journal of neurology.

[11]  T. Inoue,et al.  Formalin fixed brains are useful for magnetic resonance imaging (MRI) study , 1987, Journal of the Neurological Sciences.

[12]  F. Barkhof,et al.  Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T. , 1992, AJNR. American journal of neuroradiology.

[13]  J. V. van Noort,et al.  Fractionation of central nervous system myelin proteins by reversed-phase high-performance liquid chromatography. , 1994, Journal of chromatography. B, Biomedical applications.

[14]  S. Hauser,et al.  Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. , 1997, Journal of immunology.

[15]  R. Ferrante,et al.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease. , 1994, The Journal of clinical investigation.

[16]  Imaging of remyelination , 1997, Multiple sclerosis.

[17]  H. Lassmann,et al.  The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement , 1991, Journal of Neuroimmunology.

[18]  D. N. Landon,et al.  Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.

[19]  M. Jonker,et al.  Experimental allergic encephalomyelitis in rhesus monkeys: I. Immunological parameters in EAE resistant and susceptible rhesus monkeys. , 1987, Clinical and experimental immunology.

[20]  F. Barkhof,et al.  Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. , 1992, AJR. American journal of roentgenology.

[21]  B. Champion,et al.  Immunoregulation in the common marmoset, Calithrix jaccus: functional properties of T and B lymphocytes and their response to human interleukins 2 and 4. , 1990, Immunology.

[22]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[23]  K. Jellinger,et al.  Patterns of oligodendroglia pathology in multiple sclerosis. , 1994, Brain : a journal of neurology.

[24]  H. Tobi,et al.  Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.

[25]  N. Patronas,et al.  Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.

[26]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  N. Letvin,et al.  Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis , 1995, Annals of neurology.

[29]  R. Bontrop,et al.  Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques. , 1995, International immunology.